Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Opportunities and Threats in the Indian Pharmaceutical Industry

Posted on: Tuesday, 26 June 2007, 09:15 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c60759) has announced the addition of "The Indian Pharmaceutical Industry" to their offering.

The report describes various aspects of the Indian Pharmaceutical Industry and focuses the various opportunities and threats that have emerged as a result of change in the regulatory environment.

The report stresses on the following issues:

The current state of the Indian pharmaceutical industry and past growth trends

The change in the regulatory environment of the industry with the advent of product patent regime

New opportunities and threats that have emerged for the Indian pharmaceutical companies as a result of these regulatory changes

The value road for Indian pharma companies that describes the strategic options available for achieving long term sustainable growth

Explanation of various business and R&D strategies pursued by Indian pharma companies

Analysis of the generics opportunity in the regulated markets

Strategic mapping of top Indian pharmaceutical companies showing their relative position with respect to the value road

A brief overview of ten major pharmaceutical companies in India and various strategies followed by them

Areas covered:

The Global Pharmaceutical Market: An Overview

The Indian Pharmaceutical Industry: An Overview

Indian Pharmaceutical Industry: Structure & classification

Indian Pharmaceutical Market: A Profile

Indian Pharmaceutical Industry: Regulatory Framework

Indian Pharmaceutical Industry Value Road

Business & R&D Strategies

Strategic Mapping of Indian Pharmaceutical Companies

Company Overview

Companies mentioned:

Ranbaxy Ltd.

Cipla Ltd.

Dr. Reddy's Laboratories Ltd.

Nicholas Piramal India Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

Matrix Laboratories Ltd.

Lupin Ltd.

Glenmark Pharmaceuticals Ltd.

Sun Pharamceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/reports/c60759


Source: Business Wire

More News in this Category


Related Articles



Rating: 3.3 / 5 (6 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required